February 09, 2023
by R. Waziry, C. P. Ryan, D. L. Corcoran, K. M. Huffman, M. S. Kobor, M. Kothari, G. H. Graf, V. B. Kraus, W. E. Kraus, D. T. S. Lin, C. F. Pieper, M. E. Ramaker, M. Bhapkar, S. K. Das, L. Ferrucci, W. J. Hastings, M. Kebbe, D. C. Parker, S. B. Racette, I. Shalev, B. Schilling & D. W. Belsky
August 22, 2022
by Megan E Ramaker, David L Corcoran, Abner T Apsley, Michael S Kobor, Virginia B Kraus, William E Kraus, David TS Lin, Melissa C Orenduff, Carl F Pieper, Reem Waziry, Kim M Huffman, Daniel W Belsky
May 25, 2022
by Susan B Racette, Valene Garr Barry, Connie W Bales, Megan A McCrory, Kathleen A Obert, Cheryl H Gilhooly, Susan B Roberts, Corby K Martin, Catherine Champagne, Sai Krupa Das
Dora Il’yasova is Associate Professor of Epidemiology and Biostatistics at the School of Public Health, Georgia State University. She is a chronic disease epidemiologist with extensive expertise in biomarker-based studies. Her long-standing interest is in biomarkers of reduction-oxidation (redox) status (most often referred to as oxidative status) and the biomarkers’ relationship to chronic conditions such as cancer, diabetes, obesity, and cardiovascular disease. Dr. Il’yasova’s research is rapidly growing into studying donor-specific endothelial colony forming (progenitor) cells (ECFCs) as a model to assess human diversity of responses to drugs and environmental hazards. She is currently working on the researching whether response to oxidative stress in donor-specific ECFC lines can capture individual resilience to oxidative stress.
March 07, 2022
by Corby K Martin, Christoph Höchsmann, James L Dorling, Manjushri Bhapkar, Carl F Pieper, Susan B Racette, Sai Krupa Das, Leanne M Redman, William E Kraus, Eric Ravussin , CALERIE™ Phase 2 Study Group
